Press release
Anticoagulants Market Size Projected To Reach $87.76 Billion By 2034 With A Cagr Of 12.7%
Anticoagulants Market
What Is the Projected Growth of the Anticoagulants Market?
In recent times, there has been a significant expansion in the anticoagulants market size. Projected growth is from $49.33 billion in 2024 to $54.39 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%. This increase during the historical period can be credited to factors such as an aging global population, a rise in cardiovascular diseases, heightened awareness of the significance of anticoagulant therapy, widened application of anticoagulants, and a growing number of cases of venous thromboembolism (VTE) and atrial fibrillation.
The market for anticoagulants is projected to experience significant expansion in the coming years, swelling to $87.76 billion in 2029 with a 12.7% compound annual growth rate (CAGR). The anticipated growth during the forecasted period is generally attributed to numerous factors such as the extended applications for innovative anticoagulant drugs, an increase in healthcare spending, the emergence of novel oral anticoagulants (NOACs) as primary treatments, financial assistance from government bodies to enhance healthcare facilities, and the expansion of healthcare infrastructure. The major trends projected in the forecast period comprise of advancements in medical technologies and diagnostic methods, incorporation of artificial intelligence and data analytics in anticoagulant therapy, a growing focus on patient education and compliance programs, in addition to the development of reversal agents.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5230
What Are the Different Anticoagulants Market Segments?
The anticoagulants market covered in this report is segmented -
1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes
2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications
5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users
Subsegments:
1) By Factor Xa Inhibitor: Rivaroxaban, Apixaban, Edoxaban, Betrixaban
2) By Heparin And LMWH (Low Molecular Weight Heparin): Unfractionated Heparin, Enoxaparin, Dalteparin, Tinzaparin
3) By Vitamin K Antagonist: Warfarin, Acenocoumarol, Phenprocoumon
4) By Other Drug Classes: Direct Thrombin Inhibitors, Antiplatelet Agents, Novel Oral Anticoagulants (NOACs)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp
What Are the Primary Drivers Shaping the Anticoagulants Market?
The rise in cardiovascular diseases is a significant factor propelling the anticoagulants market's expansion in the upcoming years. Cardiovascular diseases (CVDs), including heart and blood vessel issues, are the leading cause of death globally, with 75% of CVD fatalities recorded in low- to middle-income countries. Direct oral anticoagulants, a type of anticoagulation pharmacotherapy, are used to reduce the risk of blood clots in numerous cardiovascular conditions. For example, the Centers for Disease Control and Prevention (CDC), a US government agency, reported in May 2024 that 702,880 deaths in the United States in 2022 were attributed to heart disease, of which 371,506 were due to coronary artery disease. Moreover, each year about 805,000 individuals suffer a heart attack in the country. Hence, the rise in the incidence of cardiovascular diseases propels the growth of the anticoagulants market.
Which Companies Are Leading in the Anticoagulants Market?
Major companies operating in the anticoagulants market include GlaxoSmithKline plc, Leo Pharma A/S, Alexion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Mylan N. V., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi S. A., Apotex Inc., Aspen Pharmacare Holdings Limited, AstraZeneca plc, Bristol-Myers Squibb Company, CSL Behring, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Fresenius Kabi AG, Hikma Pharmaceuticals plc, Johnson & Johnson, Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Natco Pharma Limited, Novartis International AG, Portola Pharmaceuticals Inc., Strides Pharma Science Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited, Zydus Cadila Healthcare Limited
What Are the Major Trends Shaping the Anticoagulants Market?
Leading corporations in the anticoagulants sector are turning their focus towards innovation, particularly towards novel solutions like factor Xa inhibitor tests. This is in response to the escalating need for testing brought about by the increased uptake of direct oral anticoagulants for managing serious heart complications and the prevention of strokes. Factor Xa Inhibitor Tests provide a critical evaluation of the efficacy and safety of anticoagulant treatments which selectively inhibit factor Xa, thus averting the formation of blood clots in varying medical situations. For instance, F. Hoffmann-La Roche Ltd., a biotechnology firm originating from Switzerland, in February 2024 introduced coagulation tests for apixaban, edoxaban, and rivaroxaban. Utilizing Roche's groundbreaking reagent cassette technology, these new coagulation tests for Factor Xa inhibitors guarantee top-notch results, and effective sample processing. They also ensure standardization and automation, enhancing workflow in laboratory settings. These tests play a crucial role as they guide clinical choices for patients on direct oral anticoagulants for stroke prevention and meet the escalating global need for proficient diagnostics in managing grave conditions such as coronary artery disease and peripheral arterial disease.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report
What Are the Top Revenue-Generating Geographies in the Anticoagulants Market?
North America was the largest region in the anticoagulants market in 2024. The regions covered in the anticoagulants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Anticoagulants Market?
2. What is the CAGR expected in the Anticoagulants Market?
3. What Are the Key Innovations Transforming the Anticoagulants Industry?
4. Which Region Is Leading the Anticoagulants Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anticoagulants Market Size Projected To Reach $87.76 Billion By 2034 With A Cagr Of 12.7% here
News-ID: 3951654 • Views: …
More Releases from The Business Research Company
Key Trends Reshaping the Nucleic Acid Extraction Instruments And Reagents Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Nucleic Acid Extraction Instruments And Reagents Market Size Growth Forecast: What to Expect by 2025?
The market for nucleic acid extraction instruments and reagents has experienced a robust growth in the recent past. The market value is projected to rise from $4.56 billion in 2024 to $4.97 billion in…
Mobile ECG Devices Market Set To Soar Due To Escalating Incidence Of Heart-Relat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Mobile ECG Devices Industry Market Size Be by 2025?
In the past few years, the market size for mobile ECG devices has seen significant expansion. The growth rate is expected to rise from $115.35 billion in 2024 to $121.39 billion in 2025, indicating a compound annual…
Steady Expansion Forecast for Liver Cancer Diagnostics Market, Projected to Reac …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Liver Cancer Diagnostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for liver cancer diagnostics has seen significant expansion in the past few years. The market, which was valued at $9.69 billion in 2024, is expected to rise to $10.32 billion in…
Emerging Laser Atherectomy Devices Market Trends: Product Innovations In The Las …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Laser Atherectomy Devices Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been significant growth in the market size for laser atherectomy devices. The market is projected to expand from $1.22 billion in 2024 to $1.3 billion in 2025, reflecting a compound annual growth…
More Releases for Anticoagulant
Peptide Anticoagulant Drugs Market Massive Growth opportunity Ahead
Peptide Anticoagulant Drugs market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Peptide Anticoagulant Drugs Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply…
Anticoagulant Rodenticides Market Is Expanding So Quickly
USD Analytics Market recently introduced Global Anticoagulant Rodenticides Market study with 65+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are BASF, Bayer, Syngenta, Rentokil, LiphaTech, JT Eaton, Bell Laboratories,…
Anticoagulant Reversal Drugs Market In-Depth Analysis 2029
Fairfield Market Research offers a complete understanding of the Global Anticoagulant Reversal Drugs Market in its latest research report. The report includes an unbiased analysis of the market dynamics. The report covers growth prospects, market development potential, product profitability, supply and demand curves and predictions, and government policies.
The report has been put together using reliable tools to assess the primary and secondary data. The data is represented in the…
Anticoagulant Treatment Market 2021 | Detailed Report
The Anticoagulant Treatment market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Anticoagulant Treatment report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4988667
The Anticoagulant Treatment research report also provides…
Anticoagulants Market To See Record Break Revenue $43.42 Million By 2025 | Vitam …
Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs).…
Anticoagulant Drugs Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anticoagulant Drugs market.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/241687/global-anticoagulant-drugs-market
Global Anticoagulant Drugs Market: Forecast by Type / Application / Region
Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
According to this study, over the next five years the Anticoagulant Drugs…
